|
Symbol
|
MAQGJB | MAKGJB | LVCXLK | MAFQJB | MASEJB | AHHETQ | AHHCTQ | AAZMSP | 1270BC | AHVDTQ | AIJCTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Express Certificate with European Knock-In | Express Certificate with European Knock-In | Autocallable Notes | Certificat Express | Express Certificate with European Knock-In | Express Certificate with European Knock-In |
|
Sous-jacent
|
Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé / Novartis / UBS / Zurich | Nestlé / Novartis / UBS / Zurich | Novo Nordisk, AstraZeneca, Roche, Novartis Basket | Barry Callebaut AG / Logitech / Novartis N | AstraZeneca Plc. / Novartis AG / Roche PS / Sanofi S.A. | Nestlé S.A. / Novartis AG / Roche PS |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
30.04.2029 | 30.04.2029 | 12.11.2026 | 05.01.2029 | 05.01.2029 | 22.07.2030 | 22.07.2030 | 07.10.2033 | 16.03.2029 | 21.03.2028 | 26.10.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
- | - | - | - | - | - | - | - | - | - | - |
| Demande | - | - | - | - | - | 96,64 | 96,92 | - | 106,00 | 103,69 | 100,04 |
| Offre | - | - | - | - | - | 97,49 | 97,77 | - | 106,84 | 104,58 | 100,89 |